Investment
Features
FeesSafety
Academy
More
Pluang+

International Petroleum's Blackrod Project boosts production amid rising commodity prices, but stock lags behind.

Market News
26 Jul 2026
Seeking Alpha
View Source
Bullish
pluang ai news

International Petroleum (IPCFF) is benefiting from its Blackrod Project coming online during a period of rising commodity prices. The company has consistently repurchased shares and maintained a no-dilution policy, which has increased production per share. Despite this growth, management believes the stock price does not reflect the company's production gains, partly due to high industry volatility and geopolitical uncertainties. The energy sector remains out of favor, leading to undervalued stock prices that are expected to correct over time.

More News

Warner Bros. Discovery shares drop 4% after judge halts $110B Paramount-Skydance merger.

Warner Bros. Discovery shares drop 4% after judge halts $110B Paramount-Skydance merger.

Warner Bros. Discovery's stock fell 4% following a court decision to pause the $110 billion merger deal between Paramount and Skydance. The judge's intervention raises uncertainty about the future of this major entertainment industry consolidation. I...

Market News
Bearish
1 hour ago
Markets face triple shock from Middle East war, shipping issues, and US tariffs, threatening growth and valuations.

Markets face triple shock from Middle East war, shipping issues, and US tariffs, threatening growth and valuations.

Markets are currently dealing with a rare combination of shocks: conflict in the Middle East, renewed disruptions in shipping, and an expanding US tariff barrier. These factors push Brent crude oil prices near $100, impacting more than just energy st...

Market News
Bearish
4 hours ago
Celldex's barzolvolimab phase 3 trials enroll early; pivotal data expected by late 2026, boosting strong buy rating.

Celldex's barzolvolimab phase 3 trials enroll early; pivotal data expected by late 2026, boosting strong buy rating.

Celldex Therapeutics is rated a "Strong Buy" due to rapid enrollment in its phase 3 trials for barzolvolimab, targeting chronic spontaneous urticaria (CSU). The EMBARQ-CSU 1 and 2 trials completed enrollment six months ahead of schedule, with key dat...

Analyst Insights
Bullish
4 hours ago
Crypto shorts liquidate $18M as Bitcoin and Ethereum edge higher, signaling a short squeeze.

Crypto shorts liquidate $18M as Bitcoin and Ethereum edge higher, signaling a short squeeze.

Crypto markets saw $26.3 million in liquidations over 24 hours, dominated by $18 million in short position liquidations as Bitcoin and Ethereum prices rose modestly. This indicates a short squeeze, where bearish traders are forced to close positions ...

Market News
Bullish
4 hours ago
Tower Semiconductor sees booming AI demand but faces valuation risks at 70x 2026 EPS, prompting a Hold rating.

Tower Semiconductor sees booming AI demand but faces valuation risks at 70x 2026 EPS, prompting a Hold rating.

Tower Semiconductor is benefiting from strong AI-driven demand, with silicon-photonics revenue tripling and robust wafer commitments enhancing earnings visibility. However, its valuation is high, trading at 70 times projected 2026 earnings per share ...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App